In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

VIDEOS

GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...

GRACE and PRIME Oncology have partnered to present to you information from the prIME Oncology satellite symposium held in conjunction with the 2018...

GRACE is excited to bring to our Spanish speaking community a new series on Cancer Myths Our friend and partner, Narjust (N.J.) Duma, MD is a Chief...

GRACE is excited to bring to our Spanish speaking community a new series on Cancer Myths Our friend and partner, Narjust (N.J.) Duma, MD is a Chief...

GRACE is excited to bring to you more in our new series on surviving with cancer GRACE is excited to bring to you more in our series on surviving with...

ARTICLES

From the Grace Archives | Originally Published September 14, 2010 | By Moderators | Leave a comment The following content is offered by the moderators...
From the Grace Archives | Originally Published September 14, 2010 | By Moderators | Leave a comment The following content is offered by the moderators...
From the Grace Archives | Originally Published September 14, 2010 | By Moderators | Leave a comment The following content is offered by the moderators...
From the Grace Archives | Originally Published September 3, 2010 | By Kelay Trentham | 4 Comments Kelay Trentham, a nutritionist with a particular...

From the Grace Archives | Originally Published September 2, 2010 | By Kelay Trentham | 6 Comments GRACE was fortunate enough to have Kelay Trentham, a...

COMMUNITY FORUM

I know I am probably too young (25), but at what point should I see a doctor. I have had back pains near my shoulder blade for a few months and I...
My husband has stage VI bone metastasis NSCLC since 2014. He is currently taking Targrisso second line and Xgeva. He recently went to the dentist...
Having a few questions about initial signs of lung cancer due to recent symptoms of sore throat, chest discomfort, and shoulder / shoulder blade /...
Hi, My mother is currently on Alimta infusions ( 4th dosage), Her primary side effect since the start was severe nerve pain, which was under control...
I am new here looking for advice if this is a right place. Annual CT scans have identified a stable right upper lobe Ground Glass Nodule (GGN)...

Recent Comments

Hello JGromo and welcome to…
Comment By Amy B on Feb 14, 2023 9:28 am
Thank you!
Comment By Amy B on Feb 14, 2023 9:28 am
From Dr. West, He reminds us…
Comment By Amy B on Feb 14, 2023 9:28 am
This is the response via…
Comment By Amy B on Feb 14, 2023 9:28 am

Tough decision between a whole brain radiation vs occipital craniotomy

My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to experience different vision artifacts and visual migraines but with no pain. Radiation oncologist had a hard time differentiating between radiation necrosis or cancer recurrence. In 2015 the visual migraines began to come with headaches and the headaches later became intolerable. Finally, on Dec 12, 2015 a second occipital craniotomy was performed. Among the massive necrotic tissues, the surgeon found viable cancer cells.

Case Based Panel Discussion - Advanced Non Squamous NSCLC, High PD-L1, No Driver Mutation - What is the Optimal 1st Line?

Video

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios.  In this video, the doctors discuss the optimal 1st line treatment for a patient with advanced non squamous  non small cell lung cancer, high PD-L1, and no driver mutation.

Case Based Panel Discussion - Advanced Non Squamous NSCLC, Low PD-L1 No Driver Mutation - Is There a Best Systemic Therapy Option?

Video

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios.  In this video, the doctors discuss if there is a best systemic therapy option for a patient with advanced non-squamous NSCLC, low PD-L1 and no driver mutation.

Tagrisso for acquired resistance to Tarceva

My wife has come a long way with Stage IV lung cancer since 2010. She has now developed acquired resistance to Tarceva.

Gene sequence of biopsy from enlarged pre-vascular and supraclavicular lymph nodes revealed mutation remains EGFR L858R in EXON 21 (original mutation from 2011) and negative to T790M. The cancer is also PD-1 and PD-L1 negative.

Case Based Panel Discussion - What is the Optimal Approach for a Fit Patient with Advanced Squamous NSCLC and Low Tumor PD-L1 Expression

Video

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal approach for a fit patient with advanced squamous NSCLC and low tumor PD-L1 expression. 

Targeted therapy for Exon20

Hi Grace community,
Thank you for the extensive information and great support on your website.
It seems that after 9,5 years I have developed resistance to Alimta, which has been the main reason why I have survived so long with stage IV BAC Adenocarcinoma. Now I am at a crossroads thinking what next. Cancer has progressed in my lungs, but I'm still doing quite well.

regarding treatment options for moderately adenocarcinoma in lungs and metastasis in bones

Dear Team,

my mother had breast cancer 5 yrs back.compleyed surgery of breast removal and had harmone therapy for 5 yrs and recently diagnosed with metastasis in bones and adenocarcinoma in lungs

she is given biophosphonates injection for 3 days and currently undergoing radiation therapy for metastasis identified in bones region only

she completed pet ct scan, biopsy, ihc, and ct coronary angiography, chest xray.

we are trying to test EGFR, ALK, ROS1, PDL1 stating that will take 17 days to get results

Case Based Panel Discussion - Choosing Between Targeted Therapy and Immunotherapy in a Patient with an EGFR Mutation and High PDL-1 Expression

Video

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.  

Subscribe to In Treatment